Changes in bone turnover and bone loss in HIV-infected patients changing treatment to tenofovir-emtricitabine or abacavir-lamivudine.

<h4>Background</h4>Those receiving tenofovir/emtricitabine (TDF-FTC) had greater bone loss compared with abacavir/lamivudine (ABC-3TC) in a randomized simplification trial (STEAL study). Previous studies associated increased bone turnover and bone loss with initiation of antiretroviral treatment, ho...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Hila Haskelberg, Jennifer F Hoy, Janaki Amin, Peter R Ebeling, Sean Emery, Andrew Carr, STEAL Study Group
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Public Library of Science (PLoS) 2012-01-01
Sarja:	PLoS ONE
Linkit:	https://doi.org/10.1371/journal.pone.0038377
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!